| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6) (NCT05420961) | Merck Sharp & Dohme LLC | 2022-07-12 |
| A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants (NCT05412030) | GlaxoSmithKline | 2022-06-16 |
| Paediatric Pneumococcal Pneumonia in Malaysia Prior to and During Pneumococcal Conjugate Vaccine (PCV) Implementation (NCT04923035) | IMU University, Malaysia | 2021-10-13 |
| Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 (NCT05079152) | China National Biotec Group Company Limited | 2021-05-06 |
| Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4 (NCT04790851) | China National Biotec Group Company Limited | 2021-03-10 |
| Prevention of Missed Opportunities for HIV Diagnosis by Promoting HIV Testing of Patients With Pneumococcal Pneumonia at Nice University Hospital (PneumoVIH) (NCT04909268) | Centre Hospitalier Universitaire de Nice | 2020-12-01 |
| Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4 (NCT04559204) | China National Biotec Group Company Limited | 2020-09-11 |
| Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers (NCT04357522) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2020-07-01 |
| A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001) (NCT04168190) | Merck Sharp & Dohme LLC | 2019-12-06 |
| Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants (NCT03896477) | PATH | 2019-07-18 |
| Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020) (NCT03950856) | Merck Sharp & Dohme LLC | 2019-06-12 |
| Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months (NCT04108845) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2019-06-05 |
| An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years (NCT04464291) | The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) | 2019-06-01 |
| Quantitative Polymerase Chain Reaction for Improved Detection of Pneumococci in CAP "CAPTAIN" (NCT03315403) | Medical Center Alkmaar | 2018-04-05 |
| Myocardial Injury and Severe Pneumococcal Pneumonia (NCT03058211) | Alejandro Rodriguez Oviedo , MD | 2018-03-01 |
| Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above (NCT04278248) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2018-01-12 |
| Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants (NCT03197376) | PATH | 2017-06-21 |
| Evaluation of PCV Schedules in a Naive Population in Vietnam (NCT02961231) | Nagasaki University | 2016-10-01 |
| Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae (NCT02116998) | Genocea Biosciences, Inc. | 2014-09-01 |
| Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers (NCT02097472) | PATH | 2014-04-01 |
| Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia (NCT01086397) | Pfizer | 2010-02-01 |
| Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults (NCT00744263) | Pfizer | 2008-09-01 |
| Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax) (NCT03460730) | KEMRI-Wellcome Trust Collaborative Research Program | 2004-11-04 |
| Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia (NCT00429975) | Hospital Mutua de Terrassa | 2004-08-01 |
| New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia) (NCT00035269) | Pfizer | 2001-12-01 |